Your session is about to expire
← Back to Search
Duodenal Switch vs SIPS for Bariatric Surgery Candidates
Study Summary
This trial is testing whether a less complicated duodenal switch surgery is just as effective and safe as the standard duodenal switch surgery, with fewer risks for nutrition and surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a medical or mental health condition that is not well-managed.I agree not to take weight loss medications during the study.You have a very high body weight for your height (BMI between 40 and 65).I have had bariatric surgery, but it was not a gastric sleeve.I have had complex surgery in my abdomen before.
- Group 1: Standard Duodenal Switch (DS)
- Group 2: Single Anastomosis, 300 cm Loop, Duodenal Switch (SIPS)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the requirements to join this medical study?
"The parameters for enrolment in this trial necessitate that the patient has undergone bariatric surgery and falls within the age bracket of 20-65 years old. A total of 110 individuals are expected to join."
How many participants are currently being monitored for this research project?
"Affirmative. According to clinicaltrials.gov, this experiment is presently enrolling participants and was initially posted on January 1st 2017 with its most recent edit occurring on August 31 2018. 110 individuals are needed from a single trial site."
Are participants of forty years and older eligible for this clinical investigation?
"To be eligible for this trial, participants must fall between 20 and 65 years of age. Separate clinical trials exist to assess the safety and efficacy of this drug in both younger (under 18) and older (over 65) patients."
Is this research project currently recruiting participants?
"As per clinicaltrials.gov data, this medical study is presently enrolling suitable participants. It's inaugural posting was on the first day of January 2017 and its most recent edit occurred on August 31st 2018."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger